Induction of human endothelial cell growth by mildly oxidized low density lipoprotein

Atherosclerosis

Volumn 123, Issue 1-2, 1996, Pages 115-121

  Maier, Jeanette A M ^a   Barenghi, Livia ^b   Bradamante, Silvia ^b   Pagani, Franco ^c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b CNR   (Italy)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

Cell proliferation; Endothelial cells; Oxidized low density lipoprotein; Senescence

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN TISSUE; LIPID OXIDATION; NORMAL HUMAN; PRIORITY JOURNAL; SENESCENCE;

EID: 0029948866     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05793-5     Document Type: Article

References (27)

1. Leake DS. Effects of mildly oxidized low-density lipoprotein on endothelial cell function. Curr Opin Lipidol 1991;2:301-305.
2. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, Fogelman AM, Lusis AJ. Induction of endothelial cell expression of granulocyte- and monocyte-colony stimulating factors by modified low density lipoproteins. Nature 1990;344:254-257.
3. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. Minimally modified low-density lipoprotein induces monocyte chemotactic protein I in human endothelial cells and in smooth muscle cells. Proc Natl Acad Sci USA 1990;87:5134-5138.
4. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;85:1260-1266.
5. Maier JAM, Barenghi L, Pagani F, Bradamante S, Comi P, Ragnotti G. The protective role of high density lipoprotein on oxidized low density lipoprotein-induced U937/endothelial cell interactions. Eur J Biochem 1994;221:35-41.
6. Maier JAM, Barenghi L, Bradamante S, Pagani, F. Modulators of oxidized low density lipoprotein-induced hyperadhesiveness in human endothelial cells. Biochem Biophys Res Commun 1994;204:673-677.
7. Schwartz D, Andalibi A, Chaverri-Almada L, Berliner JA, Kirchgessner T, Fang ZT, Tekamp-Olson P, Lusis AJ, Gallegos C, Fogelman AM, Territo MC. Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. J Clin Invest 1994;94:1968-1973.
8. Kuzaya M, Naito M, Funaki C, Hayashi T, Asai K, Kuzuya F. Lipid peroxide and transition metals are required for the toxicity of oxidized low density lipoprotein to cultured endothelial cells. Biochem Biophys Acta 1991;1096:155-161.
9. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
10. Schwartz SM, Benditt EP. Clustering of replicating cells in aortic endothelium. Proc Natl Acad Sci USA 1976;73:651-653.
11. Lin S-J, Jan K-M, Weinbaum S, Chien S. Transendothelial transport of low density lipoprotein in association with cell mitosis in rat aorta. Arteriosclerosis 1989;9:230-236.
12. Scott-Burden T, Risiuk TJ, Hahn AW, Baur U, Box RJ, Buhler FR. Induction of growth related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem 1989;264:12582-12589.
13. Frostegard J, Wu R, Giscombe R, Lefvert AK, Nilsson J. Induction of T cell activation by oxidized low density lipoprotein. Arterioscler Thromb 1992;12:461-467.
14. Yui S, Sasaki T, Miyazaki A, Horiuchi S, Yamazaki, M. Induction of murine macrophage growth by modified low density lipoproteins. Arterioscler Thromb 1993;13:331-337.
15. Simionescu M, Simionescu N. Proathroslerotic events: pathobiochemical changes occurring in the arterial wall before monocyte migration. FASEB J 1993;7:1359-1366.
16. Bradamante S, Barenghi L, Giudici G, Vergani C. Free radicals promote modifications in plasma high density lipoprotein. Nuclear magnetic resonance analysis. Free Radic Biol Med 1992;12:193-203.
17. Barenghi L, Bradamante S, Giudici G, Vergani C. NMR analysis of low density lipoprotein oxidatively modified in vitro. Free Radic Res Commun 1990;8:175-183.
18. Maciag T, Hoover GA, Stemerman MB, Weinstein R. Serial propagation of human endothelial cells in vitro. J Cell Biol 1981;91:420-426.
19. Maier JAM, Voulalas P, Roeder D, Maciag T. Extension of the lifespan of human endothelial cells by an interleukin 1 alpha antisense oligomer. Science 1990;249:1570-1574.
20. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992;6:2591-2599.
21. Harlan JM, Levine JD, Callahan KS, Schwartz BR. Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. J Clin Invest 1984;73:706-713.
22. Hampel G, Watanabe K, Weksler B, Jaffe EA. Selenium deficiency inhibits prostacyclin release and enhances production of platelet activating factor by human endothelial cells. Biochim Biophys Acta 1989;1006:151-158.
23. Kume N, Gimbrone MA. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 1994;93:907-911.
24. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989;58:575-606.
25. Brogi E, Winkles JA, Underwood R, Clinton SK, Alberts GF, Libby P. Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. J Clin Invest 1993;92:2408-2418
26. Maier JAM, Statuto M, Ragnotti G. Senescence stimulates U937-endothelial cell interactions. Exp Cell Res 1993;208:270-274.
27. Comi P, Chiaramonte R, Maier JAM. Senescence dependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells. Exp Cell Res 1995;219:95-101.